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Abstract
Vitamin B12, a co-factor in methyl-group transfer, is important in maintaining DNA (deoxycytidine) methylation. Using two
independent assays we examined the effect of vitamin B12-deficiency (plasma vitamin B12,148 pmol/L) on DNA
methylation in women of childbearing age. Coagulated blood clot DNA from vitamin B12-deficient women had significantly
(p,0.001) lower percentage deoxycytidine methylation (3.2360.66%; n = 248) and greater [3 H]methyl-acceptance
(42,85969,699 cpm; n= 17) than DNA from B12-replete women (4.4460.18%; n = 128 and 26,04962,814 cpm; n = 11)
[correlation between assays: r = –0.8538; p,0.001; n = 28]. In contrast, uncoagulated EDTA-blood cell pellet DNA from
vitamin B12-deficient and B12-replete women exhibited similar percentage methylation (4.4560.15%; n = 77 vs.
4.4760.15%; n = 47) and [3 H]methyl-acceptance (27,37864,094 cpm; n= 17 vs. 26,61062,292 cpm; n = 11). Therefore, in
simultaneously collected paired blood samples, vitamin B12-deficiency was associated with decreased DNA methylation
only in coagulated samples. These findings highlight the importance of sample collection methods in epigenetic studies,
and the potential impact biological processes can have on DNA methylation during collection.
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Introduction
Deoxycytidine methylation (dC R 5 mdC) patterns are
transmitted through the germ line [1] and occur primarily at the
59-dC of the 59-deoxycytidine-deoxyguanosine-39 (CpG) motif in
somatic cells [2,3,4]. Methylation of transcriptional start sites can
regulate gene expression [5] by directly inhibiting transcription
factor binding [6] and by initiating chromatin recruitment [7].
This suppression may play a critical role in regulating autosomal
gene inheritance [8], X-chromosome inactivation [9,10], and
inactivation of repetitive elements [10,11,12] such as long
interspersed nuclear elements (LINEs), endogenous retroviruses,
and satellite sequences which comprise ,35% of the genome [13].
Conversely, methylation of the gene body [14,15,16] and
subsequent chromatin recruitment may promote transcription
[17]. Centromere methylation may increase chromosomal stability
[18,19], while the greater methyl-density [3,20] and nucleosome-
occupancy [21] found in exons, and the sharp transition in methyl-
density at the intron-exon boundary [3,20], may act as a marker
for splicing [22].
Differences in epigenetic patterns between individuals with
similar genetic backgrounds may account for differences in health
outcomes [23,24,25] and, as a consequence, can contribute to the
etiology of numerous health-related conditions including infertility,
stroke, atherosclerosis, obesity, insulin resistance, kidney disease,
cancer, neural tube defects and autoimmunity
[26,27,28,29,30,31]. Meanwhile, nutritional alteration of the
epigenome in utero may be persistent [32,33,34] and may
contribute to the health [34,35,36,37] of the offspring in later
life. The methyl-groups used for DNA methylation [38,39] are
derived from preformed dietary sources (choline, betaine, methi-
onine) or are generated de novo via the folate cycle (Fig. 1) – with
vitamin B12 (cobalamin) acting as co-factor in the transfer of
methyl-groups from the folate cycle to the methylation cycle. Data
from a number of small-scale human studies [40,41,42] suggest
that folate depletion and/or repletion can affect DNA methylation
in peripheral blood cells. Likewise, Friso et al. [43] reported that
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methylenetetrahydrofolate reductase (MTHFR) 677 CRT homo-
zygous subjects with a sub-optimum folate status had significantly
less 5-methyldeoxycytidine (5 mdC) than wild-genotype subjects
(regardless of folate status) or folate-replete homozygous subjects.
Our research group previously reported differences in DNA
methylation level between DNA isolated from coagulated blood
clots (which exhibited decreased 5 mdC) vs. uncoagulated EDTA-
blood cell pellets (which exhibited no change in 5 mdC) that were
dependent on folic acid supplementation and the discontinuation
of supplementation in a population-based trial of folic acid
supplementation [44].
In humans, prolonged vitamin B12-deficiency can result in
numerous clinical ramifications including nerve damage, anemia,
digestive and cognitive problems [45]. Additionally, vitamin B12-
deficiency might be a risk factor for neural tube defects [46,47].
Despite the important role vitamin B12 plays in one-carbon
metabolism (Fig. 1) and DNA methylation, relatively little has been
reported on the effect of vitamin B12-deficiency on DNA
methylation. Rodents fed vitamin B12-deficient diets [48,49,50]
or a diet deficient in several B-vitamins [51] exhibited decreased
DNA methylation. In a single case study, Smulders et al. [52]
reported that DNA methylation increased 22% in a vitamin B12-
deficient human after vitamin B12 intervention.
The primary objective of the present study was to describe the
effect of vitamin B12-deficiency on global DNA methylation in a
female Northern Chinese population of reproductive age. This
population has a high (,21%) prevalence of vitamin B12-
deficiency (,148 pmol/L) [53,54].
Methods
Ethics Statement
Participants provided oral informed consent. This was permis-
sible as the study posed no more than minimal risk of harm to the
participant and was documented with a signature of the
consenting investigator as was culturally appropriate for the
research setting and involved no procedure for which written
consent was normally required outside of a research setting. The
study and consent procedures including a waiver for the
documentation of informed consent as set forth in
45CFR46.117(c) were approved by the Centers for Disease
Control and Prevention Institutional Review Board and the
Ethical Committee on Biomedical Research Involving Human
Subjects of the Health Science Center, Peking University. The
samples used in this study were screening samples from a folic acid
intervention study [44,55,56] - the screening/baseline samples
were used to identify suitable subjects who met the inclusion
criteria to participate in the intervention study (the intervention
trial is registered at clinicaltrials.gov: NCT00207558). No inter-
vention was performed on the subjects prior to collection of the
samples used for this manuscript.
All of the vitamin B12-deficient (plasma vitamin
B12,148 pmol/L) subjects, identified from the screening samples,
were excluded from participation in the subsequent intervention
trial and were referred for treatment.
Setting and Inclusion Criteria for Participants
Women were recruited from six townships of Xianghe County,
Hebei Province, in Northern China, for a population-based folic
acid intervention study [44,55,56]. Participants were not exposed
to dietary sources of folic acid since folic acid-fortified foods were
not available in China. Eligibility requirements included: residence
in the townships; not pregnant or breastfeeding, and not plan to
become pregnant in the next 9 months; use an IUD for
contraception; have a child 2–4 y of age; have no chronic diseases;
no supplement use within the last 3 months, and no current
prescription medication use [55].
Blood Collection Procedures
Fasting blood samples from each participant were collected into
7 ml tubes with EDTA, and 3 ml tubes containing no anticoag-
ulants (Vacutainer; Becton Dickinson).
Coagulated blood clots (blood clots) were prepared by allowing
the blood tubes, containing no anticoagulant, to stand at room
temperature for 1–2 hours, as previously described [44]. Sera were
separated by centrifugation at 2000 6 g for 15 minutes at 4uC.
After the sera were removed the blood clots were frozen and stored
at 220uC.
Uncoagulated blood cell pellets (EDTA-blood cell pellets) were
prepared within 1 hour of collection by centrifuging the EDTA
blood tubes at 2,0006 g for 15 minutes at 4uC. After the plasma
was removed the uncoagulated EDTA-blood cell pellet was frozen
at 220uC.
Blood clots and EDTA-blood cell pellets were stored at 220uC
before being transported on dry ice to the central laboratory of
Peking University Health Science Center where they were stored
at 270uC.
Biochemical Characteristics
Plasma vitamin B12 was measured in duplicate samples by
using the Quantaphase II radioassay (Bio-Rad Laboratories;
Product # 191–1044). Subjects were characterized as vitamin
B12-deficient (plasma vitamin B12,148 pmol/L; n = 305) or
vitamin B12-replete (plasma vitamin B12.148 pmol/L;
n = 1139).
Plasma and RBC folate concentrations were measured by
microbiological assay [57] while plasma homocysteine was assayed
by HPLC with fluorometric detection [58].
Sampling for % 5 mdC Analysis
Eligible subjects (n = 1,702) were enrolled in the study and
provided blood samples. Subjects with B12-deficiency
(,148 pmol/L) and clot DNA available were included as B12-
Figure 1. Schematic of the One-Carbon cycle. Vitamin B12 is a co-
factor in the transfer of methyl-groups (CH32) from folate to
methionine for use in situ methylation of deoxycytidine (dC) to in 5-
methyldeoxycytidine (5 mdC) in DNA. Choline, betaine and methionine
can be derived from the diet or synthesized in vivo. SAM: S-
adenosylmethionine; SAH: S-adenosylhomocysteine.
doi:10.1371/journal.pone.0065241.g001
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deficient (n = 248). Subjects with normal B12 status (plasma
B12.148 pmol/L) and normal hemoglobin concentration
(.120 g/L) were included as non-deficient controls (n = 128)
and were selected to have an even distribution of MTHFR
genotypes as previously reported [44]. MTHFR TT genotype was
not associated with global DNA methylation at enrollment in
either the control [44] or B12-deficient participants (not shown) in
clots and therefore was not controlled for statistically in these
analyses.
Genomic DNA Extraction
Blood clots were shipped to the University of Florida on dry ice
for genotyping and for percentage deoxycytidine methylation
determination. After the initial blood clot % 5 mdC analysis was
completed, a subset of the EDTA-blood cell pellets, which had
been retained at the Peking University Health Science Center, was
shipped on dry ice to the University of Florida for % 5 mdC
analysis.
Genomic DNA was extracted from stored frozen blood clots or
EDTA-blood cell pellets according to the manufacturer’s instruc-
tions using a commercially available blood DNA purification kit
(Gentra Puregene, Qiagen, Valencia, CA). Samples were hydrated
in TE buffer, and DNA concentration determined by fluorescent
dye binding assay (Quant-iT, Invitrogen; Carlsbad, CA) and
adjusted to 20 ng/ml. No systematic attempt was made to
determine or compare DNA yield from each blood sample matrix.
However, the amount of DNA extracted was within the expected
range (based on the extraction kit handbook and experience
extracting similar samples) and did not appear to differ between
the two matrices, nor between vitamin B12-deficient or replete
samples.
Percentage Deoxycytidine Methylation
After digesting the DNA to nucleosides [59] the concentrations
of dC and 5 mdC were determined by LC-MS/MS using
biosynthetic [15N3]dC and [
15N3]5 mdC internal standards [60].
Percentage deoxycytidine methylation (% 5 mdC) was calculated
as % 5 mdC = [5 mdC]/([dC]+[5 mdC])6100. Inter- and intra-
assay variation (relative standard deviation; n = 6) for the assay was
,2.5%.
Enzymatic [3H]Methyl-acceptance
The extent to which the CpG motif in DNA was unmethylated
was determined by [3H]methyl-acceptance assay using a modifi-
cation of the method of Balaghi and Wagner [61], as previously
described [40].
Due to the large inter-assay variability reported [40] for the
[3H]methyl-acceptance assay the number of DNA samples
analyzed was limited to the number that could be assayed within
a single assay. Consequently, 17 pairs of DNA from vitamin B12-
deficient subjects and 11 pairs from vitamin B12-replete subjects
were analyzed within the same assay. The vitamin B12-deficient
paired samples were chosen (based on the %MdCyt results of their
blood clot DNA) so as to give a range of DNA methylation levels.
Assay Comparison
Regression analysis was performed to determine the relationship
between the [3H]methyl-acceptance and % 5 mdC blood clot
DNA results. Data from the vitamin B12-deficient (n = 17) and
replete (n = 11) groups were included in the regression analysis.
Statistical Analysis
Arithmetic means and standard deviations were calculated to
compare participant characteristics. Paired t-tests were used to test
for matrix effects within the vitamin B12-deficient or replete
groups; pooled t-tests were used to test for differences between
vitamin B12-deficient and replete groups. For all tests that did not
reach statistical significance, power analyses [62] were conducted
to estimate minimum detectable percentage difference in means
(power .80%). All variables were log transformed to achieve
normal distributions for regression analysis. Univariate and
multivariate linear regression was conducted with SPSS (SPSS
Inc. Released 2009. PASW Statistics for Windows, Version 18.0,
Chicago: SPSS Inc.).
Results
Biochemical Characteristics
Physical and biochemical characteristics of the subjects included
in this analysis are presented in (Table 1).
Percentage Deoxycytidine Methylation
Blood clot DNA exhibited a significantly lower (p,0.001)
percentage deoxycytidine methylation (% 5 mdC) in vitamin B12-
deficient samples compared to vitamin B12-replete samples
(Table 2), such that there was little overlap in % 5 mdC between
the vitamin B12-deficient and replete samples (Fig. S1). Reanalysis
of different subsets of blood clot DNA from vitamin B12-deficient
Table 1. Basic Biochemical Characteristics of Subjects.
B12-replete1 B12-deficient2
mean (SD) mean (SD) Pooled t-test
n 128 248
Age (y) 30.3 (4.0) 31.5 (4.1) 0.011
Body mass index (kg/m2) 24.0 (4.4) 24.1 (3.8) 0.704
Plasma vitamin B12 (pmol/L) 284 (106) 113 (28) ,0.001
Plasma folate (nmol/L) 10.1 (4.9) 9.6 (5.7) 0.399
Red cell folate (nmol/L) 683 (315) 535 (224) ,0.001
Total plasma homocysteine (mmol/L) 8.7 (5.6) 13.3 (11.0) ,0.001
1Subjects with plasma vitamin B12 more than 148 pmol/L.
2Subjects with plasma vitamin B12 less than 148 pmol/L.
doi:10.1371/journal.pone.0065241.t001
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subjects over several months demonstrated (Fig. S2) the repro-
ducibility of the % 5 mdC assay (r .0.9; p,0.001).
Analysis of DNA extracted from EDTA-blood cell pellets
detected no differences in % 5 mdC (Table 2) between the vitamin
B12-deficient and replete subjects.
Enzymatic [3H]Methyl-acceptance Assays
Blood clot DNA from vitamin B12-deficient subjects exhibited
significantly (p,0.001) greater [3H]methyl-acceptance than blood
clot DNA from vitamin B12-replete subjects (Table 3). In contrast,
there was no apparent difference in [3H]methyl-acceptance
between the vitamin B12-deficient EDTA-blood cell pellet DNA
and either the vitamin B12-replete blood clot or EDTA-blood cell
pellet DNA.
Assay Comparison
When % 5 mdC and [3H]methyl-acceptance results, for blood
clot DNA (17 vitamin B12-deficient and 11 vitamin B12-replete
samples), were plotted against each other (Fig. 2) a significant
inverse correlation (r = –0.8538; p,0.001; n = 28) was observed.
Linear Regression
To further explore the decrease in % DNA methylation
observed in the B12-deficient participants’ coagulated samples,
univariate and multivariate linear regression was used (n = 248).
Factors examined included: plasma vitamin B12 concentration
(within deficiency), RBC folate concentrations, hemoglobin, age,
body mass index (BMI) and homocysteine concentration. In
multivariate linear regression models, DNA methylation level was
only statistically significantly associated with homocysteine
(p = 0.04; b=20.145) and hemoglobin concentrations
(p = 0.002; b=20.210).
Discussion
We observed a significantly different response to vitamin B12-
deficiency in the two simultaneously collected blood sample
matrices (blood clot vs. EDTA-blood cell pellet) studied; namely,
blood clot DNA exhibited hypomethylation, while EDTA-blood
cell pellet DNA did not. The extent (Table 2) and range (Fig. 2,
Fig. S1) of DNA hypomethylation observed were of a similar
magnitude to that previously reported [43] in elderly humans, and
were comparable to those observed in rodents fed vitamin B12-
Table 2. Effect of vitamin B12-deficiency on % 5 mdC1 for DNA extracted from coagulated blood clots2 and uncoagulated EDTA-
blood cell pellets3.
All Samples4 Matched Samples5
Blood clot Blood pellet Blood clot
n mean (SD) n mean (SD) mean (SD) Pooled t-test (p)
B12-replete6 128 4.44 (0.18) 47 4.47 (0.15) 4.45 (0.17) 0.451*
B12-deficient7 248 3.23 (0.66) 77 4.45 (0.15) 2.88 (0.86) ,0.001
Paired t-test ,0.001 0.367* ,0.001
1Methyldeoxycytidine as a percentage of total deoxycytidine in DNA digests, measured by LC-MS/MS (see Methods).
2Post-centrifugation, blood clots were retained after serum was removed from serum blood tubes.
3Post-centrifugation, blood cell pellets were retained after plasma was removed from EDTA-blood tubes.
4Results for all assayed blood clot DNA.
5Matched data for blood clot and EDTA-blood cell pellet DNA from the same subjects.
6Subjects with plasma vitamin B12 more than 148 pmol/L.
7Subjects with plasma vitamin B12 less than 148 pmol/L.
*Power analysis: .80% confidence to detect a 2% difference in means [62].
doi:10.1371/journal.pone.0065241.t002
Table 3. Effect of vitamin B12-deficiency on % 5 mdC1 and [3 H]methyl-acceptance capacity2 for DNA extracted from coagulated
blood clots3 and uncoagulated EDTA-blood cell pellets4.
% 5 mdC [3 H]methyl-acceptance (cpm/250 ng)
[mean (SD)] [mean (SD)]
n Clot DNA Pellet DNA Paired t-test Clot DNA Pellet DNA Paired t-test
B12-replete5 11 4.41 (0.12) 4.44 (0.12) 0.311* 26,049 (2,814) 26,610 (2,292) 0.626**
B12-deficient6 17 2.63 (1.16) 4.33 (0.16) ,0.001 42,859 (9,699) 27,378 (4,094) ,0.001
Pooled t-test ,0.001 0.070* ,0.001 0.577***
1Methyldeoxycytidine as a percentage of total deoxycytidine in DNA digests, measured by LC-MS/MS (see Methods).
2Capacity of DNA to incorporate [3 H] from [3 H-methyl]SAM (cpm incorporated per 250 ng DNA) in the presence of Sssi DNA methyltransferase (see Methods).
3Post-centrifugation, blood clots were retained after serum was removed from plain blood tubes.
4Post-centrifugation, blood pellets were retained after plasma was removed from EDTA blood tubes.
5Subjects with plasma vitamin B12.148 pmol/L.
6Subjects with plasma vitamin B12,148 pmol/L.
Power analysis: .80% power to detect a *4%, **10%, or ***15% difference in means [62].
doi:10.1371/journal.pone.0065241.t003
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deficient [48,49,50] or multivitamin-deficient [51] diets. The
differences in DNA methylation between the two sample matrices
were confirmed using two independent measures of DNA
methylation: a quantitative determination of the extent dC
methylation (the % 5 mdC assay) and a qualitative determination
of non-methylated CpG (the [3 H]methyl-acceptance assay).
We reported a similar effect of sample matrix on % 5 mdC in
the healthy (non-anemic, non-B12-deficient) participants following
folic acid supplementation and discontinuation of supplementation
[44]; DNA extracted from blood clots exhibited significant
changes in % 5 mdC, while EDTA-blood cell pellet DNA,
collected at the same time from the same subjects, exhibited no
change in % 5 mdC. In the present study, we were able to
extensively validate (Table 3; Fig. 2) these % 5 mdC results by
comparing the results with those obtained using an independent
assay ([3 H]methyl-acceptance assay). Additionally, we found that
this phenomenon occurs in response to another perturbation to
one-carbon metabolism – vitamin B12-deficiency.
This disparity in response between the two blood sample
matrices is of concern as it suggests that sample collection may
have as significant an impact on apparent DNA methylation as
in vivo biochemical conditions. While we examined only two
sample matrices, coagulated blood clots and uncoagulated EDTA-
blood cell pellets, questions must be asked whether DNA
methylation is as labile in other blood matrices (e.g., whole blood,
blood spots), using other anticoagulants (e.g., citrate, heparin), in
other tissue types (e.g., cell biopsies, cell culture, buccal cells) or
using different sample preparation techniques. This effect should
be taken into consideration when comparing epigenetic markers
that were determined using different methods.
The difference in % 5 mdC between sample matrices, cannot
be explained by a difference in DNA quality (e.g., denatured,
fragmented), as the DNA is digested to nucleosides as part of the
assay, and so is independent of DNA quality. Poor DNA quality
can decrease [3 H]methyl-acceptance (as the enzyme only
methylates double stranded DNA). If the EDTA-blood clot
DNA was hypomethylated, a decrease in DNA quality might
explain why the [3 H]methyl-acceptance was not elevated.
However, the magnitude of the decrease in DNA quality would
have to be just enough so that the [3 H]methyl-acceptance
appeared normal (Table 3), and would not explain the % 5 mdC
result.
The extensive use of the [3 H]methyl-acceptance assay in this
study, and the inverse correlation (r = –0.8538; p,0.001) observed
between it and the % 5 mdC assay (Fig. 2) provides important
information about the samples. Firstly, it independently confirms
Figure 2. Plot of % 5-methyldeoxycytidine versus [3H]methyl-acceptance capacity of DNA extracted from coagulated blood clots.
DNA samples were from (N) vitamin B12-deficient (plasma vitamin B12,148 pmol/L) or (%) vitamin B12-replete subjects (plasma vitamin
B12.148 pmol/L). % 5-methyldeoxycytidine: 5-methyldeoxycytidine as a percentage of total deoxycytidine in DNA digests as measured by LC-MS/
MS (see Methods). [3 H]Methyl-acceptance: [3 H] (cpm) from [3 H-methyl]SAM incorporated into 250 ng of DNA in the presence of Sssi DNA
methyltransferase.
doi:10.1371/journal.pone.0065241.g002
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the results of the % 5 mdC assay: that blood clot DNA from
vitamin B12-deficient subjects appears hypomethylated, while
EDTA-blood cell pellet DNA from the same subjects does not.
Secondly, it suggests that the difference in methylation between
the sample matrices is primarily due to interconversion between
dC and 5 mdC; rather than the simple loss or gain of 5 mdC, or
the modification of 5 mdC (e.g., to 5-hydroxymethyl-dC (5 hmdC)
[63,64]). Whether dC«5 mdC interconversion occurred in vivo or
during sample collection and processing is not clear.
Possible Mechanisms for the Differences in Methylation
Observed between Sample Matrices
Difference in blood cell composition between blood
sample matrixes. The DNA methylation is similar in mono-
nuclear and polynuclear peripheral blood cells [65], and in the
white blood cell population as a whole. Therefore, differences in
nucleated cell populations between the blood clot and EDTA-
blood cell pellet are unlikely to explain the differences in DNA
methylation.
DNA methylation became altered in the EDTA-blood cell
pellet. Use of EDTA as anticoagulant may have inadvertently
triggered DNA ‘remethylation’: By scavenging metal cations
EDTA may decreased inhibition of the DNA methyltransferases
[66]. Chelation of magnesium by EDTA may also decrease
interaction between DNMT3L and the DNA methyltransferases
[67], changing the mode of DNA methylation from processive to
distributive [68,69].
However, it is not clear where the methyl-groups needed to
‘remethylate’ the DNA would come from: The human genome is
comprised of an estimated 6.166109 bases [70] of which
,1.256109 (,2.1610215 moles) are dC [71]. To methylate 1%
of the dC to 5mdC (e.g., to elevate the mean % 5 mdC from 3.4%
to 4.4%) would require 2.1610217 moles of SAM per cell.
Ignoring all the other methyltransferase reaction in leukocytes
[72], this is 4.5 times greater than the SAM concentration in
lymphocyte (4.7610218 moles/cells*) [73] and exceeds the SAM
synthesis rate in mononuclear blood cells (,2610217 mol/hr/cell)
[74,75,76]. This imbalance between SAM usage and availability
may be particularly acute in vitamin B12-deficiency as the activity
of both methionine synthase [77,78,79,80] and SAM synthase [78]
may be decreased, thereby decreasing SAM concentrations
[78,80].
[*NOTE: there is a typographical error in [Table 3] of
Reference [73] – the SAM concentration should read ‘pmol/
106’ cells, not ‘nmol/106’ (S.J. James, personal communication).].
DNA methylation became altered in the blood
clot. Several pathways [Fig 3] have been proposed to explain
the active conversion of 5 mdC to dC observed in embryogenesis
[81,82], in some cancers [83], and during reactivation of
epigenetically suppressed or imprinted genes [84,85,86]. Some of
these reactions (5 mdC deaminase (Fig. 3; Reaction 3) [84,87] and
5 hmdC dehydroxymethylase (Fig. 3; Reaction 5) [88,89] only
occur at low SAM concentrations suggesting that DNA demeth-
ylation may have occur only in vitamin B12-deficient clots.
Alternatively, DNA demethylation and remethylation may be
ubiquitous in all blood clots, but the methylation capacity of
vitamin B12-deficient cells may have been insufficient [90] to
restore normal DNA methylation levels.
Conclusions
These findings raise questions concerning whether DNA
methylation can be influenced by the sample collection method.
In addition to the two blood matrices described, these findings
might have implications for other tissue types. If vitamin B12-
deficiency causes DNA hypomethylation in vivo this level of
hypomethylation would have clear epigenetic implications. More-
over, this study suggests that the hypomethylation observed in
blood clot DNA (whether it is representative of in vivo methylation
or not) might be a good biomarker for perturbations to the
methylation cycle and has possible implications for the health
impacts of alterations in one-carbon metabolism.
Supporting Information
Figure S1 Percentage 5-methyldeoxycytidine in blood
clot DNA. DNA from (e) vitamin B12-replete (plasma vitamin
B12.148 pmol/L) and (¤) vitamin B12-deficient (plasma vitamin
B12,148 pmol/L) subjects. Hashmarks to the outside of each
group represent mean 6 SD. Spacing along the X-axis is used
only to show individual data points. See Text for further detail.
(PDF)
Figure S2 Reproducibility of the 5-methyldeoxycytidine
LC-MS/MS assay. Subsets of blood clot DNA from vitamin
B12-deficient subjects (plasma vitamin B12,148 pmol/L) were
analyzed at different times over a two-year period and compared
to results from the primary (n = 248) DNA assay. % 5-
methyldeoxycytidine: 5-methyldeoxycytidine as a percentage of
total deoxycytidine in DNA digests as measured by LC-MS/MS
(see Methods). The broken line represents unity (X = Y). See Text
for further details.
(PDF)
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Figure 3. Putative mechanisms for the conversion of 5 mdC to
dC in DNA. Reactions: 1) 5 mdC nucleases [91]; 2) 5 mdC glycosylase
[92,93,94]; 3) 5 mdC deaminase [84,87,95,96]; 4) thymine-DNA glycosy-
lases [97]; 5) 5 mdC hydroxylase [63,64]; 6) 5 hmC glycosylase [98]; 7) AP
endonuclease/phosphodiesterase [99,100]; 8) DNA polymerase/DNA
ligase [100]; 9) 5 hmdC dehydroxymethylase [88,89]; 10) DNA demethy-
lase [101,102,103].
doi:10.1371/journal.pone.0065241.g003
B12-Status and Sample Matrix Alter DNA Methylation
PLOS ONE | www.plosone.org 6 June 2013 | Volume 8 | Issue 6 | e65241
References
1. Anway MD, Cupp AS, Uzumcu M, Skinner MK (2005) Epigenetic
Transgenerational Actions of Endocrine Disruptors and Male Fertility. Science
308: 1466–1469.
2. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, et al. (2009) Human
DNA methylomes at base resolution show widespread epigenomic differences.
Nature 462: 315–322.
3. Laurent L, Wong E, Li G, Huynh T, Tsirigos A, et al. (2010) Dynamic changes
in the human methylome during differentiation. Genome Research 20: 320–
331.
4. Ziller MJ, Mu¨ller F, Liao J, Zhang Y, Gu H, et al. (2011) Genomic Distribution
and Inter-Sample Variation of Non-CpG Methylation across Human Cell
Types. PLoS Genet 7: e1002389.
5. Zhang Z, Liu J, Kaur M, Krantz ID (2012) Characterization of DNA
methylation and its association with other biological systems in lymphoblastoid
cell lines. Genomics 99: 209–219.
6. Hsieh CL (1994) Dependence of transcriptional repression on CpG
methylation density. Molecular and Cellular Biology 14: 5487–5494.
7. Razin A (1998) CpG methylation, chromatin structure and gene silencing-a
three-way connection. EMBO J 17: 4905–4908.
8. Bartolomei MS, Tilghman SM (1997) Genomic imprinting in mammals.
Annual Review of Genetics 31: 493–525.
9. Heard E, Clerc P, Avner P (1997) X-CHROMOSOME INACTIVATION IN
MAMMALS. Annual Review of Genetics 31: 571–610.
10. Yoder JA, Walsh CP, Bestor TH (1997) Cytosine methylation and the ecology
of intragenomic parasites. Trends in Genetics 13: 335–340.
11. Walsh CP, Chaillet JR, Bestor TH (1998) Transcription of IAP endogenous
retroviruses is constrained by cytosine methylation. Nat Genet 20: 116–117.
12. Jones PA, Takai D (2001) The Role of DNA Methylation in Mammalian
Epigenetics. Science 293: 1068–1070.
13. Smit A (1996) The origin of interspersed repeats in the human genome.
Current Opinion in Genetics & Development 6: 743–748.
14. Wolf SF, Jolly DJ, Lunnen KD, Friedmann T, Migeon BR (1984) Methylation
of the hypoxanthine phosphoribosyltransferase locus on the human X
chromosome: implications for X-chromosome inactivation. Proceedings of
the National Academy of Sciences 81: 2806–2810.
15. Hellman A, Chess A (2007) Gene Body-Specific Methylation on the Active X
Chromosome. Science 315: 1141–1143.
16. Larsen F, Gundersen G, Lopez R, Prydz H (1992) CpG islands as gene markers
in the human genome. Genomics 13: 1095–1107.
17. Jones PA (1999) The DNA methylation paradox. Trends in Genetics 15: 34–
37.
18. Xu GL, Bestor TH, Bourc’his D, Hsieh CL, Tommerup N, et al. (1999)
Chromosome instability and immunodeficiency syndrome caused by mutations
in a DNA methyltransferase gene. Nature 402: 187–191.
19. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R (1998) DNA
hypomethylation leads to elevated mutation rates. Nature 395: 89–93.
20. Hodges E, Smith AD, Kendall J, Xuan Z, Ravi K, et al. (2009) High definition
profiling of mammalian DNA methylation by array capture and single
molecule bisulfite sequencing. Genome Research 19: 1593–1605.
21. Schwartz S, Meshorer E, Ast G (2009) Chromatin organization marks exon-
intron structure. Nat Struct Mol Biol 16: 990–995.
22. Zhou Y, Lu Y, Tian W (2012) Epigenetic features are significantly associated
with alternative splicing. BMC Genomics 13: 123.
23. Eckhardt F, Beck S, Gut IG, Berlin K (2004) Future potential of the Human
Epigenome Project. Expert Rev Mol Diagn 4: 609–618.
24. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, et al. (2005) From The
Cover: Epigenetic differences arise during the lifetime of monozygotic twins.
PNAS 102: 10604–10609.
25. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, et al.
(2008) Intra-individual change over time in DNA methylation with familial
clustering. JAMA 299: 2877–2883.
26. Brena RM, Costello JF (2007) Genome-epigenome interactions in cancer. Hum
Mol Genet 16: R96–105.
27. Wilson AS, Power BE, Molloy PL (2007) DNA hypomethylation and human
diseases. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1775: 138–
162.
28. Wilkinson LS, Davies W, Isles AR (2007) Genomic imprinting effects on brain
development and function. Nat Rev Neurosci 8: 832–843.
29. Gluckman PD, Hanson MA, Buklijas T, Low FM, Beedle AS (2009) Epigenetic
mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev
Endocrinol 5: 401–408.
30. Hammoud SS, Nix DA, Hammoud AO, Gibson M, Cairns BR, et al. (2011)
Genome-wide analysis identifies changes in histone retention and epigenetic
modifications at developmental and imprinted gene loci in the sperm of infertile
men. Human Reproduction 26: 2558–2569.
31. Juriloff DM, Harris MJ (2000) Mouse models for neural tube closure defects.
Human Molecular Genetics 9: 993–1000.
32. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, et al. (2008) Persistent
epigenetic differences associated with prenatal exposure to famine in humans.
Proceedings of the National Academy of Sciences 105: 17046–17049.
33. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, et al. (2009) DNA
methylation differences after exposure to prenatal famine are common and
timing- and sex-specific. Human Molecular Genetics 18: 4046–4053.
34. Hughes L, van den Brandt P, de Bruine A, Wouters K, Hulsmans S, et al.
(2009) Early life exposure to famine and colorectal cancer risk: a role for
epigenetic mechanisms. PLoS One 4: e7951.
35. Xu MQ, Sun WS, Liu BX, Feng GY, Yu L, et al. (2009) Prenatal Malnutrition
and Adult Schizophrenia: Further Evidence From the 1959–1961 Chinese
Famine. Schizophrenia Bulletin 35: 568–576.
36. Sinclair KD, Allegrucci C, Singh R, Gardner DS, Sebastian S, et al. (2007)
DNA methylation, insulin resistance, and blood pressure in offspring
determined by maternal periconceptional B vitamin and methionine status.
Proceedings of the National Academy of Sciences 104: 19351–19356.
37. Hughes LA, van den Brandt PA, Goldbohm RA, de Goeij AF, de Bruı¨ne AP, et
al. (2010) Childhood and adolescent energy restriction and subsequent
colorectal cancer risk: results from the Netherlands Cohort Study. International
Journal of Epidemiology 39: 1333–1344.
38. Finkelstein JD (1998) The metabolism of homocysteine: pathways and
regulation. European Journal of Pediatrics 157: S40–S44.
39. Quinlivan EP, Davis SR, Shelnutt KP, Henderson GN, Ghandour H, et al.
(2005) Methylenetetrahydrofolate Reductase 677CRT Polymorphism and
Folate Status Affect One-Carbon Incorporation into Human DNA Deoxynu-
cleosides. The Journal of Nutrition 135: 389–396.
40. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB (2000)
Genomic DNA methylation decreases in response to moderate folate depletion
in elderly women. The American Journal of Clinical Nutrition 72: 998–1003.
41. Shelnutt KP, Kauwell GPA, Gregory Iii JF, Maneval DR, Quinlivan EP, et al.
(2004) Methylenetetrahydrofolate reductase 677CRT polymorphism affects
DNA methylation in response to controlled folate intake in young women. The
Journal of Nutritional Biochemistry 15: 554–560.
42. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, et al. (1998)
Moderate folate depletion increases plasma homocysteine and decreases
lymphocyte DNA methylation in postmenopausal women. Journal of Nutrition
128: 1204–1212.
43. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, et al. (2002) A
common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects
genomic DNA methylation through an interaction with folate status.
Proceedings of the National Academy of Sciences 99: 5606–5611.
44. Crider KS, Quinlivan EP, Berry RJ, Hao L, Li Z, et al. (2011) Genomic DNA
methylation changes in response to folic acid supplementation in a population-
based intervention study among women of reproductive age. PLoS One 6:
e28144.
45. Moore E, Mander A, Ames D, Carne R, Sanders K, et al. (2012) Cognitive
impairment and vitamin B12: a review. Int Psychogeriatr: 1–16.
46. Hovdenak N, Haram K (2012) Influence of mineral and vitamin supplements
on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol.
47. Molloy AM, Kirke PN, Brody LC, Scott JM, Mills JL (2008) Effects of folate
and vitamin B12 deficiencies during pregnancy on fetal, infant, and child
development. Food Nutr Bull 29: S101–111; discussion S112–105.
48. Brunaud L, Alberto J, Ayav A, Gerard P, Namour F, et al. (2003) Effects of
vitamin B12 and folate deficiencies on DNA methylation and carcinogenesis in
rat liver. Clin Chem Lab Med 41: 1012–1019.
49. Brunaud L, Alberto J, Ayav A, Gerard P, Namour F, et al. (2003) Vitamin B12
is a strong determinant of low methionine synthase activity and DNA
hypomethylation in gastrectomized rats. Digestion 68: 133–140.
50. Choi SW, Friso S, Ghandour H, Bagley PJ, Selhub J, et al. (2004) Vitamin B-12
Deficiency Induces Anomalies of Base Substitution and Methylation in the
DNA of Rat Colonic Epithelium. The Journal of Nutrition 134: 750–755.
51. Liu Z, Choi SW, Crott JW, Keyes MK, Jang H, et al. (2006) Mild depletion of
vitamin B2, B6 and B12 superimposed on mild folate depletion: Effects on
DNA methylation, uracil incorporation and gene expression in the mouse
colon. AACR Meeting Abstracts 2006: 916-a-.
52. Smulders YM, Smith DEC, Kok RM, Teerlink T, Swinkels DW, et al. (2006)
Cellular folate vitamer distribution during and after correction of vitamin B12
deficiency: a case for the methylfolate trap. British Journal of Haematology
132: 623–629.
53. Hao L, Yang QH, Li Z, Bailey LB, Zhu JH, et al. (2008) Folate status and
homocysteine response to folic acid doses and withdrawal among young
Chinese women in a large-scale randomized double-blind trial. The American
Journal of Clinical Nutrition 88: 448–457.
54. Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, et al. (2007) High Prevalence of
Hyperhomocysteinemia in Chinese Adults Is Associated with Low Folate,
Vitamin B-12, and Vitamin B-6 Status. The Journal of Nutrition 137: 407–413.
55. Hao L, Yang QH, Li Z, Bailey LB, Zhu JH, et al. (2008) Folate status and
homocysteine response to folic acid doses and withdrawal among young
Chinese women in a large-scale randomized double-blind trial. Am J Clin Nutr
88: 448–457.
56. Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, et al. (2011) MTHFR 677C -
. T genotype is associated with folate and homocysteine concentrations in a
large, population-based, double-blind trial of folic acid supplementation.
American Journal of Clinical Nutrition 93: 1365–1372.
B12-Status and Sample Matrix Alter DNA Methylation
PLOS ONE | www.plosone.org 7 June 2013 | Volume 8 | Issue 6 | e65241
57. O’Broin S, Kelleher B (1992) Microbiological Assay on Microtitre Plates of
Folate in Serum and Red-Cells. Journal of Clinical Pathology 45: 344–347.
58. Araki A, Sako Y (1987) Determination of Free and Total Homocysteine in
Human-Plasma by High-Performance Liquid-Chromatography with Fluores-
cence Detection. Journal of Chromatography-Biomedical Applications 422:
43–52.
59. Quinlivan EP, Gregory JF 3rd (2008) DNA digestion to deoxyribonucleoside: a
simplified one-step procedure. Anal Biochem 373: 383–385.
60. Quinlivan EP, Gregory JF 3rd (2008) DNA methylation determination by
liquid chromatography-tandem mass spectrometry using novel biosynthetic [U-
15N]deoxycytidine and [U-15N]methyldeoxycytidine internal standards. Nucl
Acids Res: gkn534.
61. Balaghi M, Wagner C (1993) DNA Methylation in Folate Deficiency: Use of
CpG Methylase. Biochemical and Biophysical Research Communications 193:
1184–1190.
62. Lenth RV (2006–9) Java Applets for Power and Sample Size Lenth, R. V.
63. Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, et al. (2010) Role of
Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell
mass specification. Nature 466: 1129–1133.
64. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al. (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian
DNA by MLL Partner TET1. Science 324: 930–935.
65. Wu H, Delgado-Cruzata L, Flom J, Kappil M, Ferris J, et al. (2011) Global
methylation profiles in DNA from different blood cell types. Epigenetics 6: 76–
85.
66. Suetake I, Miyazaki J, Murakami C, Takeshima H, Tajima S (2003) Distinct
Enzymatic Properties of Recombinant Mouse DNA Methyltransferases
Dnmt3a and Dnmt3b. Journal of Biochemistry 133: 737–744.
67. Kareta MS, Botello ZM, Ennis JJ, Chou C, Che´din F (2006) Reconstitution
and Mechanism of the Stimulation of de Novo Methylation by Human
DNMT3L. Journal of Biological Chemistry 281: 25893–25902.
68. Holz-Schietinger C, Reich NO (2010) The Inherent Processivity of the Human
de Novo Methyltransferase 3A (DNMT3A) Is Enhanced by DNMT3L. Journal
of Biological Chemistry 285: 29091–29100.
69. Van Emburgh BO, Robertson KD (2011) Modulation of Dnmt3b function
in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants.
Nucleic Acids Research.
70. Human Genome Sequencing C (2004) Finishing the euchromatic sequence of
the human genome. Nature 431: 931–945.
71. Russell GJ, Walker PMB, Elton RA, Subak-Sharpe JH (1976) Doublet
frequency analysis of fractionated vertebrate nuclear DNA. Journal of
Molecular Biology 108: 1–20.
72. Malinow M, Axthelm M, Meredith M, MacDonald N, Upson B (1994)
Synthesis and transsulfuration of homocysteine in blood. J Lab Clin Med 123:
421–429.
73. Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ (2000) Measurement of
Plasma and Intracellular S-Adenosylmethionine and S-Adenosylhomocysteine
Utilizing Coulometric Electrochemical Detection: Alterations with Plasma
Homocysteine and Pyridoxal 59-Phosphate Concentrations. Clinical Chemistry
46: 265–272.
74. Kotb M, Kredich NM (1985) S-Adenosylmethionine synthetase from human
lymphocytes. Purification and characterization. Journal of Biological Chemistry
260: 3923–3930.
75. LeGros HL, Geller AM, Kotb M (1997) Differential Regulation of Methionine
Adenosyltransferase in Superantigen and Mitogen Stimulated Human T
Lymphocytes. Journal of Biological Chemistry 272: 16040–16047.
76. Dietz AA, Czebotar V (1977) Purine Metabolic Cycle in Normal and Leukemic
Leukocytes. Cancer Research 37: 419–426.
77. Yamada K, Kawata T, Wada M, Isshiki T, Onoda J, et al. (2000) Extremely
Low Activity of Methionine Synthase in Vitamin B-12–Deficient Rats May Be
Related to Effects on Coenzyme Stabilization Rather than to Changes in
Coenzyme Induction. The Journal of Nutrition 130: 1894–1900.
78. Doi T, Kawata T, Tadano N, Iijima T, Maekawa A (1989) Effect of vitamin
B12 deficiency on S-adenosylmethionine metabolism in rats. J Nutr Sci
Vitaminol (Tokyo) 35: 1–9.
79. Hallam L, Sawyer M, Clark A, Van der Weyden M (1987) Vitamin B12-
responsive neonatal megaloblastic anemia and homocystinuria with associated
reduced methionine synthase activity. Blood 69: 1128–1133.
80. Kennedy DG, Blanchflower WJ, Scott JM, Weir DG, Molloy AM, et al. (1992)
Cobalt-Vitamin B-12 Deficiency Decreases Methionine Synthase Activity and
Phospholipid Methylation in Sheep. The Journal of Nutrition 122: 1384–1390.
81. Mayer W, Niveleau A, Walter J, Fundele R, Haaf T (2000) Embryogenesis:
Demethylation of the zygotic paternal genome. Nature 403: 501–502.
82. Oswald J, Engemann S, Lane N, Mayer W, Olek A, et al. (2000) Active
demethylation of the paternal genome in the mouse zygote. Current Biology
10: 475–478.
83. Patra SK, Patra A, Zhao H, Dahiya R (2002) DNA methyltransferase and
demethylase in human prostate cancer. Molecular Carcinogenesis 33: 163–171.
84. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, et al. (2008)
Cyclical DNA methylation of a transcriptionally active promoter. Nature 452:
45–50.
85. Bruniquel D, Schwartz RH (2003) Selective, stable demethylation of the
interleukin-2 gene enhances transcription by an active process. Nat Immunol 4:
235–240.
86. Hajkova P, Erhardt S, Lane N, Haaf T, El-Maarri O, et al. (2002) Epigenetic
reprogramming in mouse primordial germ cells. Mechanisms of Development
117: 15–23.
87. Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, et
al. (2008) Transient cyclical methylation of promoter DNA. Nature 452: 112–
115.
88. Liutkeviciute Z, Lukinavicius G, Masevicius V, Daujotyte D, Klimasauskas S
(2009) Cytosine-5-methyltransferases add aldehydes to DNA. Nat Chem Biol 5:
400–402.
89. Chen CC, Wang KY, Shen CKJ (2012) The Mammalian de Novo DNA
Methyltransferases DNMT3A and DNMT3B Are Also DNA 5-Hydroxy-
methylcytosine Dehydroxymethylases. Journal of Biological Chemistry 287:
33116–33121.
90. Batra V, Sridhar S, Devasagayam TPA (2010) Enhanced one-carbon flux
towards DNA methylation: Effect of dietary methyl supplements against c-
radiation-induced epigenetic modifications. Chemico-Biological Interactions
183: 425–433.
91. Steinberg RA (1995) Enzymic removal of 5-methylcytosine from poly(dG-5-
methyl-dC) by HeLa cell nuclear extracts is not by a DNA glycosylase. Nucleic
Acids Research 23: 1621–1624.
92. Vairapandi M, Liebermann DA, Hoffman B, Duker NJ (2000) Human DNA-
demethylating activity: A glycosylase associated with RNA and PCNA. Journal
of Cellular Biochemistry 79: 249–260.
93. Vairapandi M (2004) Characterization of DNA demethylation in normal and
cancerous cell lines and the regulatory role of cell cycle proteins in human DNA
demethylase activity. Journal of Cellular Biochemistry 91: 572–583.
94. Kress C, Thomassin H, Grange T (2006) Active cytosine demethylation
triggered by a nuclear receptor involves DNA strand breaks. Proceedings of the
National Academy of Sciences 103: 11112–11117.
95. Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, et al. (2008) DNA
Demethylation in Zebrafish Involves the Coupling of a Deaminase, a
Glycosylase, and Gadd45. Cell 135: 1201–1212.
96. Wijesinghe P, Bhagwat AS (2012) Efficient deamination of 5-methylcytosines in
DNA by human APOBEC3A, but not by AID or APOBEC3G. Nucleic Acids
Research.
97. Neddermann P, Gallinari P, Lettieri T, Schmid D, Truong O, et al. (1996)
Cloning and Expression of Human G/T Mismatch-specific Thymine-DNA
Glycosylase. Journal of Biological Chemistry 271: 12767–12774.
98. Cannon SV, Cummings A, Teebor GW (1988) 5-hydroxymethylcytosine DNA
glycosylase activity in mammalian tissue. Biochemical and Biophysical
Research Communications 151: 1173–1179.
99. Demple B, Herman T, Chen DS (1991) Cloning and expression of APE, the
cDNA encoding the major human apurinic endonuclease: definition of a family
of DNA repair enzymes. Proceedings of the National Academy of Sciences 88:
11450–11454.
100. Lindahl T (1993) Instability and decay of the primary structure of DNA.
Nature 362: 709–715.
101. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M (1999) A mammalian
protein with specific demethylase activity for mCpG DNA. Nature 397: 579–
583.
102. Cervoni N, Bhattacharya S, Szyf M (1999) DNA Demethylase Is a Processive
Enzyme. Journal of Biological Chemistry 274: 8363–8366.
103. Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M (1999) DNA
methylation is a reversible biological signal. Proceedings of the National
Academy of Sciences 96: 6107–6112.
B12-Status and Sample Matrix Alter DNA Methylation
PLOS ONE | www.plosone.org 8 June 2013 | Volume 8 | Issue 6 | e65241
